| Financial Year |
March 31 2023 |
| Monetary Funds |
738,741,450.09 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
17,409,970.11 |
| Advances to Suppliers |
33,332,231.69 |
| Other Receivables |
7,473,568.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
34,706,792.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,907,319.38 |
| Total Current Assets |
880,571,332.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
18,148,581.82 |
| Investment Properties |
-- |
| Fixed Assetes |
689,353,311.02 |
| Under-construction Projects |
545,819,897.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
152,077,477.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,384,066.18 |
| Deferred Income Tax Assets |
4,506,514.12 |
| Other Non-Current Assets |
12,423,620.24 |
| Sub-Total of Non-Current Assets |
1,501,418,172.92 |
| Total Assets |
2,381,989,505.83 |
| Short-Term Loans |
60,067,375.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,940,000.00 |
| Accounts Payable |
183,600,852.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,743,144.16 |
| Taxes Payable |
11,526,373.25 |
| Interest Payable |
-- |
| Dividend Payable |
6,000,000.00 |
| Other payables |
19,396,927.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,516,853.66 |
| Other Current Liabilities |
3,878,976.05 |
| Sub-Total of Current Liabilities |
353,624,189.04 |
| Long-term Loans |
170,039,784.89 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,844,564.40 |
| Other Non-Current Liabilities |
1,746,936.09 |
| Sub-Total of Non-Current Liabilities |
221,215,818.24 |
| Total Liabilities |
574,840,007.28 |
| Paid-In Capital(Or Share Stock) |
282,880,000.00 |
| Capital Surplus |
813,041,927.54 |
| Surplus Reserve |
65,388,982.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
546,444,022.26 |
| Minority Stockholder's Interest |
56,932,256.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,750,217,242.28 |
| Owner's Equity（Stockholder's Equity） |
1,807,149,498.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,381,989,505.83 |
